Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Fuentes-Albero M, Cauli O
S5A), suggesting that the deletion of Gclc was localized to the liver
R.BuseJ
19 ManabeT.HenekaM
Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response
URLs : Tickets: Brochure: Prices : Drug Developer - Conference + Workshop Day: USD 4397.00, Academic - Conference + Workshop Day: USD 3797.00, Solution Provider - Conference + Workshop Day: USD 5397.00, Drug Developer - Conference Only: USD 3099.00, Academic - Conference Only: USD 2699.00, Solution Provider - Conference Only: USD 3899.00 Speakers : Alok Pachori, Medical Director, Global Development, AstraZeneca, Kristin Fiorino, Medical Director, AstraZeneca, Fady Botros, Associate Vice President, Cardiometabolic Health Clinical Research Design, Eli Lilly, Belle Van Rosmalen, Director, Medical Development, Eli Lilly, Maria Trujillo, Senior Director, Quantitative Pharmacology and Pharmacometrics, Merck, Allison Goldfine, Executive Director, Translational Medicine, Cardiovascular and Metabolism, Novartis BioMedical Research, Rosemarie Sellati, Senior Director, Global Patient Advocacy, Regeneron, Adriana Ramos, Principal Scientist and Head of Lab, Sanofi, Bryan Jones, Chief Operating Officer, Aardvark Therapeutics, Steffen-Sebastian Bolz, Co-Founder, Executive Board Member and Chief Scientific Officer, Aphaia Pharma, Dr
US$ 22.07
US$ 20.37
US$ 29.59
